Hims & Hers Health, Inc. 10-Q

Item 3. Quantitative and Qualitative Disclosures about Market Risk Interest Rate Risk Our exposure to interest rate fluctuations relate primarily to our cash and cash equivalents and short-term investments. We had cash and cash equivalents and short-term investments totaling $322.7 million and $300.3 million, as of March 31, 2025 and December 31, 2024, respectively, which were held for working capital purposes. As of March 31, 2025, our cash and cash equivalents are comprised of interest-bearing cash accounts and money market funds, and our short-term investments are comprised of U.S. Treasury bills and corporate bonds. Our investments are made for capital preservation purposes. We do not hold or issue financial instruments for trading or speculative purposes. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk. Foreign Currency Risk There was no significant foreign currency risk for the three months ended March 31, 2025 and 2024 since we operate primarily in the United States. Our operations in the United Kingdom are not considered significant. Accordingly, we believe we do not have a material exposure to foreign currency risk. We may choose to focus on international expansion in the future, which may increase our exposure to foreign currency exchange risk.